Treatment of clinically significative diabetic macular edema: influence of bevacizumab, triamcinolone and the combination of both plus macular grid thermal laser photocoagulation of subthreshold
Latest Information Update: 04 Jul 2007
At a glance
- Drugs Bevacizumab (Primary) ; Triamcinolone
- Indications Diabetic macular oedema
- Focus Therapeutic Use
- Acronyms BTP-CSME
- 04 Jul 2007 New trial record.